Edimer Pharmaceuticals

Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002

Role: lead

Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia

Role: lead

Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Role: lead

Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia

Role: collaborator

A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200

Role: lead

Phenotypic Properties in Individuals Affected With XLHED

Role: lead

X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey

Role: lead

Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status

Role: lead

Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia

Role: lead

Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)

Role: lead

Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A

Role: lead

Sweat Duct Imaging in Mother/Newborn Dyads

Role: lead

Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation

Role: lead

Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype

Role: lead

Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal Dysplasia

Role: collaborator